NCT05945537View on ClinicalTrials.gov

A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH

PHASE1RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

May 15, 2025

Study Completion Date

June 15, 2025

Conditions
Non-alcoholic Steatohepatitis
Interventions
DRUG

INI-822 (A)

Different dose levels of INI-822

OTHER

Placebo (B)

Matching placebo to INI-822

Trial Locations (7)

2050

RECRUITING

Royal Prince Alfred Hospital, Camperdown

2747

RECRUITING

Nepean Hospital, Kingswood

3004

RECRUITING

The Alfred Hospital, Melbourne

3065

RECRUITING

St. Vincent's Hospital Melbourne, Fitzroy

4102

RECRUITING

Princess Alexandra Hospital, Woolloongabba

5000

RECRUITING

CMAX Clinical Research, Adelaide

5011

RECRUITING

The Queen Elizabeth Hospital, Woodville

All Listed Sponsors
lead

Inipharm Australia Pty Ltd

INDUSTRY